Richards JC, Beahrs OH, Woolner LB. Squamous cell carcinoma of the anus, anal canal, and rectum in 109 patients. Surg Gynecol Obstet. 1962;114:474–82.
CAS
PubMed
Google Scholar
Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer. 1999;85(8):1686–93.
CAS
Google Scholar
Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2014;40(10):1165–76.
CAS
PubMed
Google Scholar
Fairley CK, Brotherton JM, Hillman R, Grulich AE. Why a special issue on anal cancer and what is in it? Sex Health. 2012;9(6):501–3.
PubMed
Google Scholar
Wong MT, Lim JF, Eu KW. Anal canal malignancies: a review in an Asian population. Singap Med J. 2011;52(1):9–14.
CAS
Google Scholar
Sun P, Li YH, Wang W, Chen CQ, Wang LY. Malignancies of the anal canal: a multi-center retrospective analysis in South China population. J BUON. 2014;19(1):103–8.
PubMed
Google Scholar
Morton M, Melnitchouk N, Bleday R. Squamous cell carcinoma of the anal canal. Curr Probl Cancer. 2018;42(5):486–92.
PubMed
Google Scholar
Jin F, Stein AN, Conway EL, Regan DG, Law M, Brotherton JM, Hocking J, Grulich AE. Trends in anal cancer in Australia, 1982-2005. Vaccine. 2011;29(12):2322–7.
PubMed
Google Scholar
Nelson VM, Benson AB 3rd. Epidemiology of Anal Canal Cancer. Surg Oncol Clin N Am. 2017;26(1):9–15.
PubMed
Google Scholar
Simpson S, Turner R. Four decades of anal cancer in Tasmania, Australia: what do the case data tell us? Sex Health. 2012;9(3):213–9.
PubMed
Google Scholar
Fish R, Sanders C, Williamson PR, Renehan AG. Core outcome research measures in anal cancer (CORMAC): protocol for systematic review, qualitative interviews and Delphi survey to develop a core outcome set in anal cancer. BMJ Open. 2017;7(11):e018726.
PubMed
PubMed Central
Google Scholar
Bertisch B, Franceschi S, Lise M, Vernazza P, Keiser O, Schoni-Affolter F, Bouchardy C, Dehler S, Levi F, Jundt G, et al. Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV cohort study. Am J Epidemiol. 2013;178(6):877–84.
PubMed
Google Scholar
Morris VK, Rashid A, Rodriguez-Bigas M, Das P, Chang G, Ohinata A, Rogers J, Crane C, Wolff RA, Eng C. Clinicopathologic features associated with human papillomavirus/p16 in patients with metastatic squamous cell carcinoma of the Anal Canal. Oncologist. 2015;20(11):1247–52.
CAS
PubMed
PubMed Central
Google Scholar
Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, Hillman RJ, Petoumenos K, Roberts J, Tabrizi SN, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol. 2012;13(5):487–500.
PubMed
Google Scholar
Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1993. 1974;36(7):709–11.
Google Scholar
Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15(5):2040–9.
CAS
PubMed
Google Scholar
UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UK Co-ordinating Committee on Cancer Research. Lancet (London, England). 1996;348(9034):1049–54.
Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996;14(9):2527–39.
CAS
PubMed
Google Scholar
Koerber SA, Schoneweg C, Slynko A, Krug D, Haefner MF, Herfarth K, Debus J, Sterzing F, von Knebel DM, Prigge ES, et al. Influence of human papillomavirus and p16(INK4a) on treatment outcome of patients with anal cancer. Radiother Oncol. 2014;113(3):331–6.
CAS
PubMed
Google Scholar
Wieghard N, Hart KD, Kelley K, Lu KC, Herzig DO, Mitin T, Thomas CR Jr, Tsikitis VL. HIV positivity and anal cancer outcomes: a single-center experience. Am J Surg. 2016;211(5):886–93.
PubMed
Google Scholar
Ries LAGYJ, Keel GE, Eisner MP, Lin YD, Horner M-J. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and tumor characteristics: National Cancer Institute, SEER Program; 2007. NIH Pub. No. 076215.
Ortholan C, Ramaioli A, Peiffert D, Lusinchi A, Romestaing P, Chauveinc L, Touboul E, Peignaux K, Bruna A, de La Roche G, et al. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or tis): therapeutic options and original pattern of local failure after radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62(2):479–85.
PubMed
Google Scholar
Read TR, Huson KL, Millar JL, Haydon A, Porter IW, Grulich AE, Hocking JS, Chen MY, Bradshaw CS, Fairley CK. Size of anal squamous cell carcinomas at diagnosis: a retrospective case series. Int J STD AIDS. 2013;24(11):879–82.
CAS
PubMed
Google Scholar
Bentzen AG, Guren MG, Wanderås EH, Frykholm G, Tveit KM, Wilsgaard T, Dahl O, Balteskard L. Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort. Int J Radiat Oncol Biol Phys. 2012;83(2):e173–80.
PubMed
Google Scholar
Mitra D, Horick NK, Brackett DG, Mouw KW, Hornick JL, Ferrone S, Hong TS, Mamon H, Clark JW, Parikh AR, et al. High IDO1 expression is associated with poor outcome in patients with anal Cancer treated with definitive Chemoradiotherapy. Oncologist. 2019.
(WHO) WHO. International classification of disease version 10. Geneva: WHO; t.
E S. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
Google Scholar
Dwyer MK, Gebski VJ, Jayamohan J. The bottom line: outcomes after conservation treatment in anal cancer. Australas Radiol. 2006;50(1):46–51.
CAS
PubMed
Google Scholar
Lewis GD, Haque W, Butler EB, Teh BS. Survival outcomes and patterns of Management for Anal Adenocarcinoma. Ann Surg Oncol. 2019;26(5):1351–7.
PubMed
Google Scholar
Li Q, Hsia J, Yang G. Prevalence of smoking in China in 2010. N Engl J Med. 2011;364(25):2469–70.
CAS
PubMed
Google Scholar
Guo H, Quan G. Tobacco control in China and the road to healthy China 2030. Int J Tuberc Lung Dis. 2020;24(3):271–7.
CAS
PubMed
Google Scholar
Pricolo VE, Viani KL, Bonvini M, Abelli CF, McDuffie TJ. Challenges in Management of Squamous Cell Carcinoma of the anus in New England and across the United States: a review of the National Cancer Data Base. Am J Clin Oncol. 2018;41(7):662–6.
PubMed
Google Scholar
Ong JJ, Walker S, Grulich A, Hoy J, Read TR. Incorporating digital anorectal examinations for anal cancer screening into routine HIV care for men who have sex with men living with HIV: a prospective cohort study. J Int AIDS Soc. 2018;21(12):e25192.
PubMed
PubMed Central
Google Scholar
Gosens KC, Richel O, Prins JM. Human papillomavirus as a cause of anal cancer and the role of screening. Curr Opin Infect Dis. 2017;30(1):87–92.
PubMed
Google Scholar
Gudur A, Shanmuganandamurthy D, Szep Z, Poggio JL. An update on the current role of high resolution Anoscopy in patients with anal dysplasia. Anticancer Res. 2019;39(1):17–23.
CAS
PubMed
Google Scholar
Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathology. 2011;119(1):5–19.
PubMed
Google Scholar
Lindsey K, DeCristofaro C, James J. Anal pap smears: should we be doing them? J Am Acad Nurse Pract. 2009;21(8):437–43.
PubMed
Google Scholar
Liszewski W, Ananth AT, Ploch LE, Rogers NE. Anal pap smears and anal cancer: what dermatologists should know. J Am Acad Dermatol. 2014;71(5):985–92.
PubMed
Google Scholar
Ong JJ, Fairley CK, Carroll S, Walker S, Chen M, Read T, Grulich A, Bradshaw C, Kaldor J, Clarke P. Cost-effectiveness of screening for anal cancer using regular digital ano-rectal examinations in men who have sex with men living with HIV. J Int AIDS Soc. 2016;19(1):20514.
PubMed
PubMed Central
Google Scholar
de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180–90.
PubMed
Google Scholar
Baricevic I, He X, Chakrabarty B, Oliver AW, Bailey C, Summers J, Hampson L, Hampson I, Gilbert DC, Renehan AG. High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: different implications for vaccine prevention and prognosis. Eur J Cancer (Oxford, England : 1990). 2015;51(6):776–85.
CAS
Google Scholar
Serrano B, de Sanjosé S, Tous S, Quiros B, Muñoz N, Bosch X, Alemany L. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Eur J Cancer (Oxford, England : 1990). 2015;51(13):1732–41.
Google Scholar
Ouhoummane N, Steben M, Coutlée F, Vuong T, Forest P, Rodier C, Louchini R, Duarte E, Brassard P. Squamous anal cancer: patient characteristics and HPV type distribution. Cancer Epidemiol. 2013;37(6):807–12.
CAS
PubMed
Google Scholar
Saleem AM, Paulus JK, Shapter AP, Baxter NN, Roberts PL, Ricciardi R. Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm. Obstet Gynecol. 2011;117(3):643–9.
PubMed
Google Scholar
Papatla K, Halpern MT, Hernandez E, Brown J, Benrubi D, Houck K, Chu C, Rubin S. Second primary anal and oropharyngeal cancers in cervical cancer survivors. Am J Obstet Gynecol. 2019;221(5):478.e471–6.
Google Scholar
Gilbert DC, Wakeham K, Langley RE, Vale CL. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis. Br J Cancer. 2019;120(2):256–68.
PubMed
Google Scholar
de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–70.
PubMed
PubMed Central
Google Scholar
Duan R, Qiao Y. Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China. Cancer Med. 2020;9(1):374–84.
PubMed
Google Scholar
Hao J. China Cancer Registry Annual Report. People’s Medical Publishing House; 2018.
Google Scholar
Ghosn M, Kourie HR, Abdayem P, Antoun J, Nasr D. Anal cancer treatment: current status and future perspectives. World J Gastroenterol. 2015;21(8):2294–302.
CAS
PubMed
PubMed Central
Google Scholar
Serup-Hansen E, Linnemann D, Skovrider-Ruminski W, Høgdall E, Geertsen PF, Havsteen H. Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American joint committee on Cancer stages I to III carcinoma of the anal canal. J Clin Oncol. 2014;32(17):1812–7.
PubMed
Google Scholar
Meulendijks D, Tomasoa NB, Dewit L, Smits PH, Bakker R, van Velthuysen ML, Rosenberg EH, Beijnen JH, Schellens JH, Cats A. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53. Br J Cancer. 2015;112(8):1358–66.
CAS
PubMed
PubMed Central
Google Scholar
Gilbert DC, Williams A, Allan K, Stokoe J, Jackson T, Linsdall S, Bailey CM, Summers J. p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: correlation with outcomes following chemo-radiotherapy. Radiother Oncol. 2013;109(1):146–51.
CAS
PubMed
Google Scholar
Jones CM, Goh V, Sebag-Montefiore D, Gilbert DC. Biomarkers in anal cancer: from biological understanding to stratified treatment. Br J Cancer. 2017;116(2):156–62.
CAS
PubMed
Google Scholar
McBride KR, Fortenberry JD. Heterosexual anal sexuality and anal sex behaviors: a review. J Sex Res. 2010;47(2):123–36.
PubMed
Google Scholar
Rissel C, Badcock PB, Smith AM, Richters J, de Visser RO, Grulich AE, Simpson JM. Heterosexual experience and recent heterosexual encounters among Australian adults: the second Australian study of health and relationships. Sex Health. 2014;11(5):416–26.
PubMed
Google Scholar